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Since its development, the bioluminescence resonance energy transfer (BRET) approach
has been extensively applied to study G protein-coupled receptors (GPCRs) in real-time
and in live cells. One of the major aspects of GPCRs investigated in considerable details
is their physical coupling to the heterotrimeric G proteins. As a result, new concepts have
emerged, but few questions are still a matter of debate illustrating the complexity of GPCR-
G protein interactions and coupling. Here, we summarized the recent advances on our
understanding of GPCR-G protein coupling based on BRET approaches and supported
by other FRET-based studies. We essentially focused on our recent studies in which we
addressed the concept of preassembly vs. the agonist-dependent interaction between the
protease-activated receptor 1 (PAR1) and its cognate G proteins. We discussed the con-
cept of agonist-induced conformational changes within the preassembled PAR1-G protein
complexes as well as the critical question how the multiple coupling of PAR1 with two
different G proteins, Gαi1 and Gα12, but also β-arrestin 1, can be regulated.
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INTRODUCTION
G protein-coupled receptors (GPCRs) constitute one of the largest
cell surface receptor family, and are involved in many cellular sig-
naling and physiological responses (Bockaert, 1991; Gether, 2000).
They are encoded by the largest gene family in the mammalian
genomes and they constitute the site of binding and action of a
large panel of natural mediators such as hormones and neuro-
transmitters (Bockaert and Pin, 1999). Thus, GPCRs are known
to be the target of many drugs used to treat diseases (Schlyer and
Horuk, 2006). Initially, the cellular signaling via GPCRs has been
thought to occur only by their interaction with and activation of
several types of guanine nucleotide binding proteins or G pro-
teins (Limbird, 1983; Bockaert et al., 1987; Gilman, 1987). How-
ever, it is now obvious that in addition to G protein-dependent
signaling, GPCRs also activate G protein-independent signaling
pathways (Hermans, 2003; Lefkowitz and Whalen, 2004). Further-
more, GPCRs are now known to interact with many intracellular
proteins other than G proteins and these proteins play a major role
in promoting and regulating GPCR signaling (Brady and Limbird,
2002).
From their discovery until now, the coupling of GPCRs to the
heterotrimeric G proteins and their activation has been exten-
sively studied. The initial model explaining their functioning has
considerably evolved (Bourne, 1997; Limbird, 2004; Strange, 2008)
and new concepts have emerged such as, constitutive activity and
precoupling (Leff and Scaramellini, 1998; Seifert and Wenzel-
Seifert, 2002), multiple coupling (Hamm, 1998; Hermans, 2003;
Perez and Karnik, 2005), functional selectivity (Rajagopal et al.,
2011), and the role of GPCR oligomerization (Dean et al., 2001).
The initial ternary model of GPCR/G protein activation postulated
that agonist binding promotes the transition of the receptor from
the inactive to the active state leading to the physical association
of the receptor with the heterotrimeric Gαβγ protein, allowing
the exchange of bound GDP for GTP in the Gα subunit (Limbird
et al., 1980; Gether and Kobilka, 1998). GTP binding stabilizes
the active state of the G protein leading to the dissociation of
the receptor-G protein complex allowing Gα on one hand, and
Gβγ on the other hand to act on their respective effectors and
initiating signal transduction (Hamm, 1998; Oldham and Hamm,
2008). Moreover, it is now accepted that ligand binding to GPCRs
promotes conformational changes in the receptor leading to the
transition of the receptor to its active state. This evidence come
from the functional studies of the downstream signaling as well
as the biochemical, biophysical, and structural analysis of GPCRs
themselves (Gether et al., 1995; Vilardaga et al., 2003; Bockenhauer
et al., 2011).
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Over the past 20 years, the question of how GPCR-G protein
coupling occurs has been widely studied initially using radioli-
gand binding (Stadel et al., 1981) and biochemical techniques
(Smith and Limbird, 1981; Neumann et al., 2002) and recently
through crystallographic analysis (Palczewski et al., 2000; Kobilka
and Schertler, 2008) and energy transfer-based approaches, bio-
luminescence resonance energy transfer (BRET) and FRET (bio-
luminescence/fluorescence resonance energy transfer; Pin et al.,
2008; Vilardaga et al., 2009; Lohse et al., 2012). BRET and FRET
methods allow the determination of the proximity and/or rela-
tive orientation of two chromophores fused to the proteins being
studied, such as between a GPCR and its cognate G protein, or
between Gα and Gβγ subunits, directly in real-time and in live
cells (Azpiazu and Gautam, 2004; Frank et al., 2005; Gales et al.,
2005; Ayoub et al., 2010). As discussed in this review, these studies
challenged the initial GPCR-G protein model to some extend and
revealed new concepts with regard to receptor-G protein coupling
as well as G protein subunit dissociation.
In this review, we focus on the recent studies using the BRET
approach to investigate the physical and functional interaction
between GPCRs and the heterotrimeric G proteins taking lessons
from our observations on the interaction of the thrombin receptor,
protease-activated receptor 1 (PAR1), with Gαi1 and Gα12 as well
as β-arrestin 1 (Ayoub et al., 2007, 2009, 2010). PAR1 belongs to a
particular GPCR family composed by three other subtypes, PAR2,
PAR3, and PAR4, known to be activated by various and highly
selective serine proteases such as thrombin, trypsin, plasmin, and
the factor Xa (Cottrell et al., 2002; Hollenberg and Compton,
2002). The activation mechanism of PARs involved the cleavage
of their N-terminal extremity by the protease, unmasking a new N
terminus that acts as a tethered ligand, directly activating the trans-
membrane core of the receptor (Coughlin, 2000). Following acti-
vation, cleaved PARs are known to undergo a rapid desensitization,
internalization, and degradation (Trejo, 2003). This desensitiza-
tion and internalization processes involve the phosphorylation of
the receptor by G protein-coupled receptor kinases and the recruit-
ment of arrestins (Trejo, 2003). PARs have been reported to play
crucial roles in a number of physiological processes such as throm-
bosis, vascular development, inflammation, cell proliferation, and
tumorigenesis and therefore they are considered as interesting tar-
gets for the treatment of various pathologies (Coughlin, 2005).
PAR1 is a prototype of the PARs family members, characterized by
the diversity of its signaling pathways involving different G pro-
tein classes as well as arrestins. Indeed, PAR1 has been reported
to couple to Gi/o, Gq as well as G12/13 proteins promoting mul-
tiple downstream signaling responses in various cellular models
(Coughlin, 2000; Marinissen et al., 2003).
BRET TO STUDY GPCR-G PROTEIN INTERACTION
As mentioned above the initial GPCR/G protein activation model
was based on elegant biochemical experiments using solubilized
and purified proteins. Thus, for a long time and before the emer-
gence of BRET and FRET techniques the detailed analysis of
GPCRs and G protein activation in real-time and in live cells was
very limited. Now such an analysis becomes feasible and indeed
within the past 7 years a number of studies has examined the
activation process of the heterotrimeric G proteins by various
GPCRs, using either FRET or BRET techniques (Vilardaga et al.,
2009; Lohse et al., 2012). The historically first energy transfer-
based assay to study G protein activation by GPCRs was based on
FRET approach using GFP variants as donor and acceptor and
the pioneer study was in Dictyostelium discoideum using FRET
between Gα and Gβγ subunits showing a direct evidence for G
protein dissociation in live cells (Janetopoulos et al., 2001). Then
other FRET studies on the activation and association/dissociation
of the G protein subunits have been reported in yeast and vari-
ous mammalian cell lines (Yi et al., 2003; Azpiazu and Gautam,
2004; Frank et al., 2005; Gibson and Gilman, 2006). These stud-
ies have reported contradictory conclusions with regard to the
dissociation or non-dissociation of Gα and Gβγ subunits after
receptor activation and this may depend on the GPCR-G protein
pair.
Later, the investigation of the interaction and activation of
GPCR-G protein complexes in real-time became possible through
the measurement of FRET or BRET signals between the activating
GPCRs themselves and either Gα, Gβ, or Gγ subunits (Gales et al.,
2005; Hein et al., 2005; Nobles et al., 2005; Galés et al., 2006; Ayoub
et al., 2007, 2010; Hasbi et al., 2007; Qin et al., 2008). These assays
are based on the fusion of the energy donor and the energy accep-
tor with the receptor (generally on its C-terminus) and one of the
G protein subunit (α or βγ at some specific position within the G
protein subunit) and their co-expression and activation by the ago-
nist (Figure 1A; Galés et al., 2006; Ayoub et al., 2007, 2010). Then
receptor-G protein interaction and the activation of the complex
are assessed either in real-time before and after agonist stimula-
tion or after agonist preincubation depending on the model used
(Figure 1B).
We will here illustrate such studies based on our recent finding
using PAR1 and different effectors. In these studies we used pro-
teins fused to either the energy donor Renilla luciferase (Rluc) or
the energy acceptor yellow fluorescent protein (YFP). The energy
transfer process between Rluc and YFP mainly depends on the
distance between the two proteins of interest and/or their rel-
ative orientation within the protein complexes (Pin et al., 2008).
Thus, the intimate interaction which is supposed to occur between
GPCRs and their specific heterotrimeric G proteins constitutes an
exciting field of investigation using BRET as a proximity- and
conformational-based approach.
To monitor GPCR-G protein interaction and activation, three
different assay configurations can be used: (i) the fusion of the
receptor with YFP (Receptor-YFP) and the Gα subunit with Rluc
(Gα-Rluc) in the presence of untagged Gβ and Gγ subunits
(Figure 2A), (ii) the fusion of the Receptor-YFP and the Gβ or
Gγ subunits with Rluc (Gβ/Gγ-Rluc) in the presence of untagged
Gα subunit (Figure 2B), and (iii) the fusion of Gα subunit with
Rluc (Gα-Rluc) and the Gβ or Gγ subunits with YFP (Gβ/Gγ-
YFP) in the presence of untagged GPCR (Figure 2C). For each
BRET assay configuration, the fusion proteins are transiently co-
expressed in cell lines and then the basal BRET signal as well as the
agonist-promoted BRET changes are measured in real-time and
live cells as previously described (Ayoub et al., 2007, 2009, 2010).
Therefore, real-time kinetic and dose-response analysis as well as
the application of specific GPCR antagonists or agents targeting G
proteins can be performed.
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FIGURE 1 | BRET assay to study receptor-G protein interactions in live
cells. (A) First, to study the interaction between a GPCR and its cognate
heterotrimeric G protein, the G protein subunit (α, β, or γ) is fused to the
energy donor, Renilla luciferase (Rluc) and the receptor is fused to the energy
acceptor, YFP, and then both fusion protein are co-expressed and BRET signal
is measured before and after receptor activation, as described previously
(Ayoub et al., 2007, 2010). (B) The standard BRET protocol is based on cell
transfection and culture in BRET compatible 96-well plates and then BRET
assay can be performed in two different ways depending on the specificities
of the model studied. In the first way, cells are first preincubated with drugs
(agonist, antagonist, inhibitor etc.,) and then BRET is measured straightaway
after the addition of Rluc substrate, Coelenterazine h. This method can be
used for slow and sustained ligand-induced interactions, such as a stable
β-arrestin recruitment or to detect irreversible BRET changes within
constitutive protein complexes. The second way consists to add
Coelenterazine h and measure BRET before any cell stimulation (basal BRET)
and then stimulate cells with drugs in the aim to detect any rapid and
transient BRET change resulted from the activation of the protein complexes.
This method is recommended to detect rapid and reversible conformational
changes within receptor-G protein complexes.
FIGURE 2 | Different BRET assay configurations to study receptor-G
protein interactions. To investigate the interaction between GPCRs and the
heterotrimeric G proteins and their activation in live cells using BRET, at least
three configurations of the assay can be used. (A) BRET between the
receptor fused to YFP and the Gα subunit, which can be Gαs, Gαi/o, Gαq, or
Gα12/13, fused to Rluc in the presence of the untagged β and γ subunits. In
this configuration, either BRET increase or decrease can be expected
depending on the receptor-G protein pair and the nature of ligand-induced
effect, conformational changes or G protein recruitment (Galés et al., 2006;
Ayoub et al., 2010). (B) BRET between the receptor fused to YFP and either
the Gβ or Gγ subunit fused to Rluc in the presence of a specific untagged Gα
subunit which could be Gαs, Gαi/o, Gαq, or Gα12/13 (Gales et al., 2005; Ayoub
et al., 2009). Similarly to the configuration A, either BRET increase or
decrease can be expected depending on the receptor-G protein pair and the
ligand-induced conformational changes. (C) BRET between a specific Gα
subunit fused to Rluc and either Gβ or Gγ fused to YFP in the presence of the
untagged receptor. In this configuration, in most cases a BRET decrease is
expected but a BRET increase is also possible (Galés et al., 2006).
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RECEPTOR-G PROTEIN PRECOUPLING/PREASSEMBLY
From the initial studies performed 30 years ago, it has become well
accepted that agonist activation of a GPCR allows its physical asso-
ciation with a heterotrimeric G protein, promoting the GDP/GTP
exchange on Gα subunit and G protein activation (De Lean et al.,
1980; Limbird et al., 1980; Gether and Kobilka, 1998). It is evident
that the study of receptor/G protein interaction has considerably
evolved during the recent last years. However, some key questions
around this subject are still unresolved and constitute a matter of
debate. The main question concerns the dynamics of the receptor-
G protein interaction and through the literature two different
models have been proposed. The first model called “free colli-
sion coupling” model postulates that both GPCRs and G proteins
diffuse freely within the plasma membrane, and only the active
receptor (i.e., agonist-activated receptor) couple to and specifi-
cally activates G proteins (Leff, 1995; Hein and Bunemann, 2009;
Lohse et al., 2012). This model corroborates the initial GPCR-G
protein model postulating that agonist binding is the prerequi-
site to GPCR-G protein physical interaction and activation and
once activated, the receptor and G proteins dissociate. In addition,
the collision model is compatible to some degree with the ternary
complex model, where agonist–receptor–G protein complex is sta-
bilized in the absence of guanine nucleotides and GTP addition is
supposed to dissociate the ternary complex. This dogma was well
accepted for a long time by most of the GPCR scientists. The sec-
ond model assumes that GPCRs and G proteins are “precoupled”
which means here the receptor and G proteins form stable com-
plexes regardless of the activation state of the receptor (Hein and
Bunemann, 2009; Lohse et al., 2012). Thus, according to this model
the agonist binding promotes receptor activation which leads to
conformational changes within the pre-existing receptor-G pro-
tein complex resulting in G protein activation without physical
dissociation between the receptor and G proteins. Of note, this
model has been proposed to explain the high constitutive activity
observed with some GPCRs (Lachance et al., 1999; Roka et al.,
1999; Seifert and Wenzel-Seifert, 2002). However, other possibili-
ties cannot be excluded such as; (i) preassociated receptors and G
proteins which dissociate upon agonist-induced receptor activa-
tion, or even (ii) the separated inactive receptors and G proteins
which form a stable complex only when the receptor is activated.
Therefore, it is possible that GPCR-G protein coupling may be
differentially structured; depending upon the specific GPCR, G
protein subtype, their expression levels and the cellular system
used as discussed previously (Vilardaga et al., 2009; Qin et al.,
2011). This will be further discussed later in this review.
Our recent data using BRET to study the physical association of
PAR1, with different G proteins revealed the existence of preassoci-
ated complex between PAR1 and Gαi1 protein (Ayoub et al., 2007,
2010), and PAR1 and Gαo (Ayoub et al., 2009) when both partners
are transiently co-expressed in COS-7 cells. Indeed, a significant
and saturable basal BRET signal was measured between Gαi1-Rluc
and PAR1-YFP in the absence of receptor activation with thrombin
or PAR1 peptide agonists. This finding was in fact not unexpected
as it can be reconciled with the “precoupling” model of GPCRs
but of course, the observation of a basal BRET signal between two
different proteins raises the question with regard to the specificity
of such a BRET signal measured under the resting condition. Our
different assays and controls using BRET and also time-resolved
FRET (TR-FRET) led us to accumulate several lines of evidence
demonstrating the specificity of PAR1-Gαi1 association and the
constitutive energy transfer signals measured. First, in contrast
to the large BRET signal between PAR1 and Gαi1, no significant
BRET signal could be detected between PAR1 and Gαs used a
negative control and expressed at similar levels than Gαi1 (Ayoub
et al., 2007, 2010). Although the absence of BRET does not mean
the absence of interaction, since the lack of energy transfer can be
the consequence of a perpendicular orientation of the dipoles, the
absence of interaction was confirmed using a TR-FRET approach
that only relies on the distance since the donor fluorophore cannot
be constraint in its orientation (Pin et al., 2008). In addition, under
similar conditions the basal BRET signal measured between Gα12-
or Gα13-Rluc and PAR1-YFP was also very weak compared to
Gαi1-Rluc (Ayoub et al., 2010) and this constitutes an interesting
observation since PAR1 is also known to activate Gα12/13 pro-
teins and this point will be discussed later. Second, the quantitative
analysis of the expression levels of PAR1 and Gαi1 clearly indicated
that the constitutive BRET signal measured cannot be explained
by the overexpression of the BRET partners since 100,000 recep-
tor molecules were expressed at the cell surface of COS-7 cells
consistent with PAR1 expression in platelets (Ayoub et al., 2007).
Third, the basal BRET signal measured between Gαi1-Rluc and
PAR1-YFP was nicely saturable and blocked by the overexpression
of an untagged Gαi1 protein demonstrating the specificity of the
signal observed (Ayoub et al., 2007). Finally, the basal BRET signal
between PAR1 and Gαi1 was also confirmed by TR-FRET devel-
oped for the first time to study GPCR-G protein interaction using
Flag- and Myc-tagged proteins and antibodies conjugated with
homogeneous TR-FRET-compatible fluorophores (Ayoub et al.,
2010). Together, these observations rule out the possibility of an
artifactual signal resulting from the overexpression of the fusion
proteins because of the heterologous system used.
Furthermore, the other aspect that we addressed is the plau-
sible link between the basal BRET measured between PAR1 and
Gαi1 and any constitutive activity of the receptor-G protein com-
plex. This is important since the precoupling model was proposed
following the observation that many GPCRs display constitutive
activity, a phenomena that would be consistent with the assembly
of G proteins with the non-activated GPCR. We found that the
constitutive BRET signal was completely insensitive to pertussis
toxin (PTX) treatment which inhibits the Gαi1 protein activa-
tion (Ayoub et al., 2007, 2010), such that the assembly observed
had nothing to do with G protein activation. Similarly, the basal
BRET signal measured between PAR1 and Gαi1 was only par-
tially diminished by BIM46187, a synthetic compound reported to
inhibit GPCR-mediated signaling mostly by disrupting the physi-
cal association between GPCRs and the Gα subunit (Ayoub et al.,
2009). Accordingly, our observation of the preassembly between
PAR1 and Gαi1 was not related to any basal activity of the recep-
tor. To clarify this issue, we considered the basal BRET observed
as the consequence of a preassembly, rather than a precoupling
that would instead be associated with a basal activation of the G
protein.
The data obtained with PAR1 using BRET and TR-FRET are
consistent with other BRET studies reporting a pre-association of
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other GPCRs such as α2A-adrenergic (Galés et al., 2006), δ-opioid
(Audet et al., 2008), chemokine CXCR4 and CXCR7 (Levoye et al.,
2009) receptors and their cognate G proteins in the absence of
receptor activation. Similar observations using other techniques
to investigate the interaction between other GPCRs and G protein
types have been reported including FRET between various GPCRs
(adrenergic α2A, Muscarinic M4, Dopamine 2S, and Adenosine
A1) with the Gαo protein (Nobles et al., 2005; Philip et al., 2007)
or FRAP between the muscarininc M3 receptor and Gαq protein
(Qin et al., 2011) that all support GPCR-G protein preassembly. In
this context, we should also include our data using TR-FRET tech-
nique showing a preassembly of Gα12 with the serotonin 5HT2c,
vasopressin V1a, and muscarinic M1 receptors, but not PAR1, in
COS-7 cells (Ayoub et al., 2010). Moreover, the GPCR-Gα pre-
assembly concept can also be supported to some extent by other
studies again based on BRET and FRET between Gα and Gβγ
revealing a constant proximity between the G protein subunits
(Bunemann et al., 2003; Galés et al., 2006). In these studies, it has
been reported that GPCR activation promotes a relative move-
ment of βγ and α subunits associated with G protein activation
which is illustrated by either a partial increase or a partial decrease
in the energy transfer efficiency following the receptor activation,
depending on the position where BRET/FRET chromophores are
inserted (Bunemann et al., 2003; Galés et al., 2006; Gibson and
Gilman, 2006). This hypothesis of a non-dissociation between Gα
and Gβγ is supported by the recent report that Gαq and Gβγ are
still in proximity after binding of GRK2 as observed in the crystal
structure of the Gαq-GRK2 complex (Tesmer et al., 2005).
All these data on GPCR-G protein preassembly in live cells
using both BRET and different FRET-based assays are in fact
supported by previous biochemical studies using coimmunopre-
cipitation between receptors and G proteins in the absence of
receptor agonists and performed in different cellular backgrounds.
This is true for D2 receptor and Gαi (Senogles et al., 1987), β2-
adrenergic receptor and Gαs (Lachance et al., 1999), δ-opioid
receptor, and Gαi (Law and Reisine, 1997), somatostatin recep-
tor and Gαi and Gαo (Law et al., 1993), AT2 receptor and Gαi
(Zhang and Pratt, 1996), melatonin MT1 receptor, and Gαi (Roka
et al., 1999). Pharmacological studies have also been useful to
demonstrate a tight association between a GPCR and its G protein
as shown for the serotonin 5-HT7 preassociated with Gαs even
in the absence of agonist (Andressen et al., 2006). As discussed
later, such a preassembly is not observed with all GPCR-G protein
couples, indicating that this cannot be considered as a general phe-
nomena involved in receptor-G protein coupling, then illustrating
the importance and the specificity of such association when it can
be observed.
These data then raised the question of the functional signifi-
cance of the basal BRET observed between a GPCR and its target
G protein. The basal BRET signal indicating a close proximity
(≤10 nm) between the receptor and the G protein may result from
their direct physical interaction even though we were unable to get
both PAR1 and Gαi1 coimmunoprecipitated when they are co-
expressed in COS-7 or HEK293 cells. This possibility is supported
by our data using BIM46187 reported to inhibit GPCR-mediated
signaling (Ayoub et al., 2009). Indeed, we have shown by both
BRET in live cells and also FRET on purified GPCR and G proteins
that BIM46187 inhibits the activation of G proteins by GPCRs by
binding to the Gα subunit and thereby blocks its physical inter-
action with the receptor (Ayoub et al., 2009). BIM46187 partially
diminished the basal BRET measured between PAR1 and Gαi1 or
Gαo indicating that part of the basal BRET signal reflects the direct
or indirect association between the receptor and the G proteins.
The other explanation is the colocalization of PAR1 and Gαi1 in
specific membrane microdomains where the limited number of
G proteins are in close vicinity to the receptor, consistent with
a saturable basal BRET signal. In fact, the high density of both
the receptor and G proteins in such microdomains (Insel et al.,
2005) may favor the energy transfer to occur between the BRET
partners. This cannot be completely excluded since we observed
that the treatment of cells with Methyl-β-cyclodextrin, which is
known to extract cholesterol from the membrane and thereby
increases membrane fluidity and disrupts microdomains, signif-
icantly increased the basal BRET signal between PAR1 and Gαi1
(unpublished data). Finally, this emerging preassembly theory to
explain some specific GPCR-G protein association are also sup-
ported by a recent study reporting that large complexes forming
by GPCRs, G proteins but also specific effectors are formed early in
the endoplasmic reticulum (Dupre et al., 2006). Together, the data
obtained with PAR1 and Gαi1 and with other GPCR-G protein
pairs are therefore more consistent with the preassembly theory
postulating that this specific molecular organization of GPCRs and
G protein would allow a faster process of G protein activation since
there is no time needed for the receptor and G protein to collide.
This is nicely illustrated by our data showing a differential nature
of the interaction of PAR1 with either Gαi1 (preassembly) or Gα12
(recruitment; Ayoub et al., 2010). In addition, a slow activation of
Gαq by a mutant of the muscarinic M3 receptor which does not
preassemble with the G protein has been reported suggesting the
importance of GPCR-G protein preassembly in accelerating sig-
naling (Qin et al., 2011). In fact, Qin et al. (2011) proposed that
preassembly may have a crucial functional role in native tissues
where the expression levels of GPCRs and/or G proteins is lower
compared to the overexpression in cell lines. Moreover, GPCR-G
protein preassembly may allow a better control of the selectivity
of the signaling cascades since one would argue that a preassem-
bled receptor has a limited availability in space (same tissue or
cell) and in time (simultaneously) to interact and couple to differ-
ent G proteins as we nicely demonstrated for PAR1 and Gαi1 and
Gα12 (Ayoub et al., 2010). The GPCR-G protein preassembly may
also control the efficiency of signaling by sequestering or limiting
access to a common G protein pool as this has been shown for
CXCR7 attenuating β-adrenergic-mediated Gαs/adenylate cyclase
activation (Andressen et al., 2006).
AGONIST-PROMOTED CONFORMATIONAL CHANGESWITHIN
THE PREASSEMBLED RECEPTOR-G PROTEIN COMPLEX
The preassembly concept raises many key questions related to
the activation mechanism of the preassembled GPCR-G pro-
tein complexes and the consequences of the agonist activa-
tion on such complexes. What would be the dynamics of the
receptor-G protein complexes after receptor activation? Is there
any change in the complex number after activation or do GPCR
and G proteins associate further or dissociate as a consequence of
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agonist-promoted activation? All these questions continue to be a
matter of controversy in the GPCR community and this is true for
both receptor-G protein interaction and the interaction between
the different G protein subunits (α, β, and γ; Hein and Bunemann,
2009; Vilardaga et al., 2009; Lohse et al., 2012). In fact, as men-
tioned above according to the “precoupling” model if GPCRs are
preassembled with their cognate G proteins the number of G pro-
teins available for one receptor is only one or at least very limited
assuming that there is no reversible dissociation of the complex.
This is determined either during the early stage of protein syn-
thesis and/or somehow during their life in the plasma membrane
of cells. However, in the “free collision” model, a receptor has a
possibility to interact and activate many G proteins in different
coupling/uncoupling cycles as long as the agonist is available to
maintain the receptor in its active state at the cell surface.
For PAR1 and Gαi1 (and also Gαo), we observed that despite
the constitutive high BRET, the activation of PAR1 with throm-
bin or PAR1 selective agonist peptides largely increased the BRET
signal in a time- and dose-dependent manner (Ayoub et al., 2007,
2009, 2010). This agonist-increased BRET was completely blocked
by PTX (Ayoub et al., 2007, 2010), protease inhibitors and PAR1
antagonist, SCH79797 (Ayoub et al., 2007), and a non-selective G
protein inhibitor, BIM46187 (Ayoub et al., 2009) clearly demon-
strating that agonist-induced BRET increase between PAR1 and
Gαi1 reflects the activation of their preassembled complex. The
EC50 values of thrombin (∼0.5 – 6 nM) and PAR1 selective ago-
nist peptides (∼6µM) measured in BRET assay are consistent
with the activation of PAR1 in a functional assay (Ayoub et al.,
2007). Moreover, the kinetic analysis showed a rapid and transient
BRET increase between PAR1 and Gαi1 after agonist application
(t 1/2= 4.3± 0.6 s for thrombin; Ayoub et al., 2007, 2010). Indeed,
thrombin-induced BRET increase persists for a few minutes before
returning to the basal level and the decay kinetic of thrombin-
induced BRET between PAR1 and Gαi1 (t 1/2= 6.9± 1.7 min)
paralleled the kinetic of thrombin-promoted β-arrestin 1 recruit-
ment also measured by BRET (t 1/2= 5.4± 0.9 min; Ayoub et al.,
2007) or TR-FRET (t 1/2= 7.5± 1.5 min; Ayoub et al., 2010) indi-
cating the desensitization of the activated PAR1-Gαi1 complex.
Furthermore, the decay of the induced BRET signal did not go
beyond the basal level (Ayoub et al., 2007, 2010) further sup-
ports the concept of a preassembled receptor-G protein com-
plex being formed even in the absence of activation and non-
dissociated after receptor activation. It is important to point
out here that the agonist-promoted PAR1-Gαi1 activation mea-
sured in BRET assay is still slower compared to what has been
reported in the others studies (Hein et al., 2005; Galés et al.,
2006) as well as what was expected for GPCR-G protein acti-
vation process. This may be due to the limitation of our BRET
assay and/or the luminescence reader used for such a kinetic
analysis. A difference in the activation kinetic between different
GPCRs as reported between the PTH and α2-adrenergic recep-
tors (Vilardaga et al., 2003) or a difference in the feature of the
interaction observed between various GPCR-G protein pairs as we
found between PAR1 and Gα12 (Ayoub et al., 2010) may be other
reasonable explanations. More interestingly, BRET assay allowed
us to detect the transition of PAR1-Gαi1 complex from the inac-
tive to the active state in an agonist-dependent manner and this
supports the different models implying that GPCRs and G pro-
teins exist in at least two different states (De Lean et al., 1980; Leff,
1995).
How can the rapid and transient agonist-induced BRET
increase between PAR1 and Gαi1 be interpreted? Our studies
and others clearly agree that such BRET changes reflect confor-
mational changes within the preassembled receptor-G protein
complex rather than a further recruitment of G proteins to the
activated receptors, resulting from a change of either the distance
or the orientation of the chromophores (Galés et al., 2006; Ayoub
et al., 2007, 2010; Levoye et al., 2009; Figure 3A). First, in BRET sat-
uration assay between PAR1 and Gαi1 no difference in the BRET50
value, corresponding to 50% of the BRET saturation value, was
observed when cells were stimulated with thrombin (Ayoub et al.,
2007), consistent with an absence of any change in their relative
affinity, and then arguing against an increase BRET due to further
recruitment of new G proteins. However, the maximal BRET sig-
nal was largely increased consistent with a movement occurring
between Rluc and YFP during activation of the preassembled com-
plex. Second, we observed that depending on the insertion position
of BRET donor and acceptor (Rluc and YFP) in the receptor and/or
G protein, the BRET increase observed after PAR1 activation was
not always detectable (Ayoub et al., 2007). Similarly, Galés et al.
(2006) have nicely shown that depending on the position of Rluc
within the G protein either an increase or a decrease in BRET sig-
nal after receptor activation was observed, not consistent with the
recruitment of new G proteins (Galés et al., 2006). Third, a signif-
icant basal BRET signal between Gαi1 and a wild-type CXCR4 as
well as its mutant (CXCR4-N119K), which cannot activate G pro-
teins, has been reported, indicating that the preassembly between
Gαi1 and CXCR4 does not require the activation of the G protein
(Levoye et al., 2009). In parallel, the wild-type CXCR4 showed a
high basal BRET which can be largely increased after receptor acti-
vation (Levoye et al., 2009). Finally, in TR-FRET assay using large
fluorophore-conjugated antibodies against Flag and Myc tags, no
FRET increase was measured between PAR1-Myc and Gαi1-Flag
after stimulation of cells with thrombin whereas thrombin nicely
and specifically promoted Gα12-Flag as well as Flag-β-arrestin
1 recruitment to the activated PAR1-Myc (Ayoub et al., 2010).
Together, these observations are a demonstration that the agonist-
induced BRET changes within PAR1-Gαi1 protein complex cannot
be a consequence of further G protein recruitment by the activated
receptor, but rather reflects a change in the relative position of the
interacting proteins associated with the activation process, lead-
ing to a change of either the distance or the orientation of the
chromophores (Figure 3A).
AGONIST-INDUCED RECEPTOR-G PROTEIN ASSOCIATION
However, some other studies have reported opposite observations
with regard to the constitutive association between GPCRs and G
proteins suggesting that preassembly is not a general feature of all
GPCR and G protein couples. Indeed, a recent study using a variant
of BRET-based assay with FKBP-Rapamycin system failed to detect
constitutive BRET signal between various class A GPCRs and dif-
ferent G proteins (Kuravi et al., 2010). Similarly, Hein et al. (2005)
have reported no specific basal FRET signal between the α2A-
adrenergic receptor and Gi in the absence of receptor activation.
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FIGURE 3 | GPCR-G protein preassembly or agonist-induced association.
(A) In the preassembly model, as shown for PAR1-Gαi1 interaction (Ayoub
et al., 2007, 2010), a basal BRET signal is measured between the receptor-YFP
and Gα-Rluc fusion proteins. Agonist stimulation induces BRET changes (here
indicated by an increase) without changing the receptor-G protein interaction
supporting agonist-induced conformational changes within the preassembled
complexes. (B) The other situation is illustrated by the data obtained with
PAR1-Gα12 interaction (Ayoub et al., 2010) where there is no significant basal
BRET signal indicating no preassembly and only receptor activation promotes
receptor-G protein association and thereby induces BRET signal increase.
In this study and in agreement with the “free collision” model,
the expression levels of the G proteins was found to determine
the kinetics of receptor-G protein interaction (Hein et al., 2005).
Moreover, Qin et al. (2011) have demonstrated that in their inac-
tive state M3R-Gαq complexes are transient and become more
stable after receptor activation. Thus, these data clearly sustain the
debate around the nature of GPCR-G protein interaction and acti-
vation since they support more the “free collision” model than the
“precoupling”one. These opposite observations however may have
different reasons: (i) GPCRs might differ in their coupling prop-
erties due to the differences in their active conformations and the
way how they activate different G proteins (Leff and Scaramellini,
1998; Hermans, 2003; Ayoub et al., 2010), (ii) the cellular model
used and the expression level of GPCRs and G proteins, and of
course (iii) the sensitivities of the different energy transfer-based
assays or other techniques used (Lohse et al., 2012).
In this context, our data with PAR1 and its interaction with
Gα12 monitored by BRET and TR-FRET have shed some light
on understanding the GPCR-G protein coupling (Ayoub et al.,
2010). Indeed, in contrast to the PAR1-Gαi1 pair for which we
observed preassembly, we found that PAR1 and Gα12 are not pre-
assembled in COS-7 cells as illustrated by very low basal BRET
and TR-FRET signals (Ayoub et al., 2010). This was not due to
the differences in the expression levels between Gαi1 and Gα12
or the position where the fluorophores were fused within the G
proteins. Moreover, the short term activation (up to 2 min) of
PAR1 had no effect on the basal BRET signal between PAR1 and
Gα12 while a large increase was observed between PAR1 and Gαi1
as mentioned above (Ayoub et al., 2010). However, a long-term
activation of PAR1 (≥10–60 min) largely increased both BRET
and TR-FRET signals between PAR1 and Gα12, in a time- and
dose-dependent manner (Ayoub et al., 2010). Thrombin- as well
as PAR1 agonist peptide-induced BRET/TR-FRET increase was
specific for PAR1-Gα12 association and it was not observed with
Gαs or even Gα13 also known to be activated by PAR1 in many
other models. Together, BRET, TR-FRET, and coimmunoprecipi-
tation experiments confirmed the physical recruitment of Gα12 to
PAR1 in an agonist-dependent way (Figure 3B). In addition, the
persistence of PAR1-Gα12 association under Triton X-100 condi-
tion used in coimmunorecipitation and TR-FRET assays clearly
illustrates the strength of such a physical interaction. These obser-
vations suggest that the stable interaction between PAR1 and Gα12
is more compatible with the“free collision model”as observed with
other GPCRs using energy-transfer approaches (Hein et al., 2005;
Qin et al., 2008; Kuravi et al., 2010). However, this recruitment is
very slow compared to what was really expected for GPCR activa-
tion kinetics and it is also very stable in time since it was observed
even 1 h after receptor activation. Gα12 recruitment to the acti-
vated PAR1 is in fact slower than Gα12 activation monitored by
p115-RhoGEF translocation to the plasma membrane (Tanabe
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et al., 2004). However, the activation of the small G protein RhoA
mediated by Gα12/13 proteins has also been reported to occur
a few minutes after G protein activation (Tanabe et al., 2004).
Unfortunately, we were unable to measure Gα12 activation by any
specific readout or signaling assay in a fast enough way to com-
pare the kinetics of Gα12 activation and recruitment to PAR1.
It is then still unclear if this slow and sustained recruitment of
Gα12 to the activated PAR1 is really associated with its activa-
tion in our model, or has other functional meanings. Moreover,
the stability of PAR1-Gα12 complex after its formation may be
explained by either a non-dissociation of the complex or many
rapid association-dissociation cycles which cannot be detected by
BRET and as a result a continuous BRET or TR-FRET signal.
Therefore, we speculated about the significance of our BRET and
TR-FRET data with Gα12 and we argued that the only reason for
Gα12 to be recruited to the receptor is indeed its activation by this
activated receptor. This is consistent with the strong and sustained
developing effects of thrombin and PAR1 on cell morphology
and proliferation where stabilizing PAR1-Gα12 interaction and
maintaining their long term activation may be crucial for the
control of cell proliferation, differentiation, migration, or onco-
genesis (Dhanasekaran and Dermott, 1996; Riobo and Manning,
2005). However, one would exclude that the stable Gα12 associa-
tion with PAR1 may inhibits subsequent receptor activation and
via a sequestration process this limits the pool of Gα12 available,
thereby reduces the action of Gα12-dependent signaling promoted
by other GPCRs as observed with the preassembly of 5-HT7 with
Gαs inhibiting this G protein to be activated by the β-adrenergic
receptor (Andressen et al., 2006).
Interestingly, the agonist-promoted Gα12 recruitment is a par-
ticular feature of PAR1 and cannot be generalized to other recep-
tors reported to couple to Gα12. Indeed, when other GPCRs such
as serotonin 5-HT2c, vasopressin V1a, and muscarinic M3 recep-
tors were tested, high constitutive TR-FRET (Ayoub et al., 2010)
and BRET (unpublished data) signals was measured between Gα12
and these receptors. Agonist stimulation had no effect on the
basal signals again illustrates that the preassembly or agonist-
induced G protein recruitment depend on receptor-G protein
pairs. Taken together with the data obtained with PAR1-Gαi1
preassembly, these observations illustrate the specificity, diver-
sity and complexity of GPCR-G protein coupling and show how
one GPCR (PAR1) can associate differently with two distinct
classes of G protein (Gαi1 and Gα12; Figure 4A), and on the
other hand how a given G protein (Gα12) is differently inter-
acting with distinct GPCRs (PAR1 and 5-HT2c, V1aR or M3R;
Figure 4B).
THE MULTIPLE COUPLING OF PAR1 TO GαI1, Gα12, AND
β-ARRESTIN 1
It is now evident that GPCRs are able to control various physiolog-
ical responses by promoting diverse signaling pathways via their
coupling to different classes of G proteins and other intracellular
proteins (Figure 5; Hamm, 1998; Hermans, 2003). As elegantly
discussed by Hermans the multiple coupling abilities of GPCRs
is selectively controlled and regulated at different levels (Table 1;
Hermans, 2003) and our data on PAR1, Gαi1, Gα12, and β-arrestin
1 and others came to complement the discussion with the new con-
cepts of preassembly and agonist-dependent G protein interaction
with some specificities for PAR1.
PAR1 can be considered as an ideal model to study such a mul-
tiple coupling since it has been shown to couple to different G
proteins including Gαi/o, Gαq, and Gα12/13 as well as to arrestins
(Coughlin, 2000; Trejo, 2003). Indeed, our studies using BRET
and TR-FRET approaches in live COS-7 cells moved one step fur-
ther in understanding how the multiple coupling of PAR1 with
Gαi1, Gα12, and β-arrestin 1 and its signaling can be regulated
and integrated. We found two main differences between the inter-
action of PAR1 with Gαi1 and Gα12. The first one consists of
the nature of the interaction, constitutive (for Gαi1; Figure 3A)
or agonist-induced (for Gα12; Figure 3B), and consequently this
results in a second difference in terms of the kinetic of their asso-
ciation with the receptor, rapid, and transient (for Gαi1) or slow
and stable (for Gα12; Figure 6). Nevertheless, another interest-
ing difference between PAR1-Gαi1 and PAR1-Gα12 coupling has
been found at the molecular level. Indeed, we have shown that the
last eight C-terminal residues of Gα12 are crucial for its associ-
ation with PAR1 in an agonist-dependent manner whereas the
corresponding region in Gαi1 does not seem to be important
FIGURE 4 | Differential association mode of Gα12 protein with PAR1 and
other GPCRs. (A) BRET and TR-FRET data demonstrated that PAR1 is
preassembled with Gαi1, but not Gα12 which is only recruited after receptor
activation (Ayoub et al., 2010). (B) In contrast to PAR1, Gα12 can be
preassembled with other GPCRs such as 5-HT2c, V1aR, and M3R (Ayoub
et al., 2010).
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FIGURE 5 |The multiple coupling of GPCRs. The diversity of GPCR
signaling as a result of the possibility of a given GPCR to couple and
activate G protein of various classes (Hermans, 2003).
Table 1 |The different levels of regulation of the multiple of GPCR-G
protein coupling.
Agonist Receptor G protein
Nature Splice variant, RNA editing Expression level
Potency Receptor density Availability
Concentration Phosphorylation Compartmentalization
Palmitoylation
Homo- and heteromeriza-
tion
Interaction with accessory
proteins
Preassembly with G pro-
teins
Regulators of G protein
signaling (RGS)
Preassembly with the
receptor
Adapted from Hermans (2003).
for preassembly. Moreover, even the mutation of the cysteine at
position-4 in Gαi1, known to be crucial for PTX-induced Gαi
protein inhibition, had no effect on PAR1-Gαi1 preassembly indi-
cating a secondary role of the C-terminal region of the Gα subunit
in the preassembly and suggesting the importance of other molec-
ular determinants within the alpha subunit. Therefore, we propose
that the preassembly between PAR1 and Gαi1 does not involve the
C-terminal of the Gα subunit, in contrast to PAR1-Gαi1 coupling
(or activation) as shown by PTX inhibiting the agonist-induced
BRET increase (Ayoub et al., 2007). Furthermore, we observed
that the deletion of a large part of PAR1 C-terminus completely
inhibited the agonist-induced BRET increase between PAR1 and
Gαi1 without affecting the high basal BRET suggesting that the
C-terminus of PAR1 likely plays a role in the functional coupling
of PAR1 with Gαi1, but not in their preassembly (Ayoub et al.,
2007).
FIGURE 6 | Kinetic profiles of the interaction of PAR1 with Gαi1, Gα12,
and β-arrestin 1. Based on BRET analysis, the kinetic of the interaction of
PAR1 with Gαi1, Gα12, and β-arrestin 1 has been found to be interestingly
different. Indeed, PAR1-Gαi1 interaction is constitutive and agonist
stimulation leads to a rapid and transient transition to the activated state of
the preassembled complex. The deactivation phase of the preassembled
PAR1-Gαi1 complex appears to be parallel to the slow and stable
recruitment of both Gα12 and β-arrestin 1 to the activated PAR1. This
difference in BRET kinetic analysis clearly suggests a differential mode of
association of PAR1 with these different proteins. Furthermore, the data
obtained with PAR1 nicely illustrate how the multiple coupling of one GPCR
to different signaling proteins can be regulated at the level of the kinetic of
the interaction/activation between the receptor and the G proteins.
Together our observations led us to propose a speculative model
based on our observations in COS-7 cells where the key element
in PAR1-G protein interaction and regulation, when Gαi1, Gα12,
and arrestins are considered in the system, is actually the exis-
tence of at least two different populations of receptors (Figure 7;
Ayoub et al., 2010). Indeed, the first population is exclusively pre-
assembled with Gαi1, but not Gα12, and this is supported by a
basal BRET and TR-FRET signals between PAR1 and Gαi1 and
the absence of any specific signal between Gαi1 and Gα12 (unpub-
lished data). This preassembled PAR1-Gαi1 population is rapidly
and transiently activated probably to control cAMP-dependent
signaling in a faster way and the deactivation process which is very
important appears to be parallel to the recruitment of β-arrestin
1. Interestingly, we found that PAR1 and Gαi1 do not dissociate
even after β-arrestin 1 being recruited to the preassembled com-
plex. Indeed, for the first time we were able to detect very high
BRET and TR-FRET signals between Gαi1 and β-arrestin 1 when
PAR1 was activated, bringing clear evidence that β-arrestin can
be recruited by a receptor still associated with Gαi1 (Ayoub et al.,
2010). This was observed only when β-arrestin 1 is recruited to
PAR1 since a mutant of PAR1 unable to interact with β-arrestin
1 did not show any specific BRET signal between Gαi1 and β-
arrestin1 despite its preassembly with Gαi1. The co-existence of
PAR1, Gαi1, and β-arrestin 1, but not Gα12, in a same complex
has nicely been confirmed for the first time using a multi-complex
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FIGURE 7 | Model of the differential mode of association of PAR1 with
Gαi1, Gα12, and β-arrestin 1. The model is based on BRET observations and
suggests the existence of two populations of PAR1, at least in COS-7 cells
(Ayoub et al., 2010). In the absence of receptor activation, one population of
PAR1 is preassembled with Gαi1 and another one would be non-associated
with any of Gαi1, Gα12, or β-arrestin 1. A short term activation of PAR1
induces a rapid activation of the preassembled PAR1-Gαi1 complex
characterized by a transient change in the relative position of PAR1 and Gαi1
without any change on free PAR1. In contrast, long term activation first results
in the deactivation of the preassembled PAR1-Gαi1 complex and in parallel to
the concomitant recruitment of both Gα12 and β-arrestin 1 to the activated
PAR1. Interestingly, even though their similar kinetic of recruitment, Gα12 and
β-arrestin 1 are not co-recruited to the same population of PAR1. Indeed, it
has been clearly demonstrated that β-arrestin 1, but not Gα12, can be
recruited by the activated PAR1-Gαi1 complex. In addition, it is not excluded
that β-arrestin 1 is also recruited by the activated free PAR1. In contrast, after
long term activation of PAR1-Gα12 seems to be translocated to the no
assembled population of PAR1 only. (Adapted from Ayoub et al. (2010)
Differential association modes of the thrombin receptor PAR1 with Gαi1,
Gα12, and β-arrestin 1. The FASEB Journal (2010), 24(9): 3522-3535).
assay based on TR-FRET approach (Ayoub et al., 2010). Having
observed that the agonist-promoted BRET increase disappeared
in parallel to β-arrestin 1 recruitment, this finding indicates that
the preassembled PAR1-Gαi1 complex is desensitized following β-
arrestin 1 recruitment to the preassembled complex, but this does
not result in a physical dissociation between PAR1 and Gαi1. Thus,
our findings essentially reconcile the GPCR-G protein preassembly
concluded from BRET studies in live cells. Although the preassem-
bly may appear consistent with the“precoupling”model, we would
like to point out here that our proposed preassembly model does
not include basal activation of the G protein, as suggested in the
precoupling model. Thus, receptor-G protein “preassembly” does
not necessarily mean their “precoupling.”
The second population of PAR1 would not be preassembled
with any of Gαi1, Gα12, β-arrestin 1. Following PAR1 activation
Gα12 is recruited to the activated receptor in slow and pro-
longed kinetics (Figure 6). In contrast to what observed with
Gαi1, Gα12 recruitment (t 1/2= 8.8± 1.9 min) was concomitant
to β-arrestin 1 recruitment (t 1/2= 7.5± 1.5 min; Ayoub et al.,
2010) suggesting a co-recruitment of Gα12 and β-arrestin 1 to the
same activated receptor. This is unlikely because, neither BRET
nor TR-FRET signal was measured between Gα12 and β-arrestin
1 after PAR1 activation (Ayoub et al., 2010). Furthermore, in a
BRET competition-based assay we found that the overexpression
of β-arrestin 1 significantly reduced PAR1-Gα12 association. In
contrast, when Gα12 was overexpressed the agonist-promoted
β-arrestin 1 recruitment was not affected at all. In addition, a
mutant of PAR1 unable to interact with β-arrestin 1 was still able
to recruit Gα12 in an agonist-dependent manner and the inhibi-
tion of thrombin-promoted PAR1 internalization, which seems to
Frontiers in Endocrinology | Molecular and Structural Endocrinology June 2012 | Volume 3 | Article 82 | 10
Ayoub et al. PAR1-G protein coupling studied by BRET
be arrestin-dependent, did not affect Gα12 recruitment. Together,
these observations indicate a competitive and exclusive recruit-
ment of Gα12 or β-arrestin 1 to the same pool of activated PAR1.
In another word, Gα12 and β-arrestin 1 cannot be recruited simul-
taneously to the same receptor and among the free population of
PAR1 molecules there are some receptor interacting with Gα12
only and others with β-arrestin 1 only but not with both. This
constitutes an interesting finding which in fact raises many other
questions regarding (i) the desensitization of PAR1-Gα12 complex
if such a complex cannot recruit arrestins while Gα12 is there, (ii)
the significance of the recruitment of β-arrestin 1 to a free PAR1 (is
this population non-associated with any G protein?), and finally
(iii) the molecular mechanisms involved in such a competitive and
exclusive recruitment of Gα12 or β-arrestin 1. Of course this needs
further investigations to be clarified.
The existence of two different populations of PAR1 is the only
explanation of our BRET and TR-FRET data. This may imply that
in the same cell the preassembled PAR1-Gαi1 complex and PAR1
susceptible to recruit Gα12 or β-arrestin 1 exist in different mem-
brane domains. Our data using methyl-β-cyclodextrin support
this hypothesis to some extent since we observed that treatment of
cells with methyl-β-cyclodextrin largely increased both basal and
agonist-induced BRET signal between PAR1 and Gαi1, but had no
effect on agonist-induced Gα12 recruitment (unpublished data).
The differential recruitment of β-arrestin 1 when PAR1-Gαi1 and
PAR1-Gα12 complexes are compared clearly demonstrates the co-
existence of at least two populations of PAR1 in COS-7 cells. Of
course, the existence of these two different populations may be
specific for our cellular model using transient expression in COS-
7 cells, but one would hypothesize that this may also occur in native
tissues. Thus, the co-expression of both Gαi1 and Gα12 proteins
with PAR1 in a same cell type and at the same time, their relative
expression levels and the involvement of other accessory intracel-
lular proteins could be the major factors controlling the existence
of the two populations of PAR1 and the preassembly or not with
the G proteins.
Together, our studies on the physical interaction of PAR1
with Gαi1, Gα12, and β-arrestin 1 using BRET and TR-FRET
approaches constitute one step further to better understand
GPCR-G protein coupling and again illustrates the complexity of
GPCR-G protein coupling. It nicely illustrates that many different
processes can be involved in this coupling mechanism, depend-
ing on the receptor-G protein couple examined. Therefore, we
conclude that the nature of the molecular association between
GPCRs and G proteins characterized by either the preassembly
or the agonist-dependent recruitment depends on the receptor-G
protein pair and this differential association between GPCR and
G proteins may constitute a novel way to control the multiple
coupling of GPCRs.
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